This sounds like a breakthrough:
Roche said its antibody test, Elecsys Anti-SARS-CoV-2, has a specificity rate of about 99.8% and sensitivity rate of 100%. The company had previously pledged to make its antibody test available by early May and to boost production by June to “high double-digit millions” per month.
The test requires an intravenous blood draw, but it could still be a game changer.
Originally Posted by: xioni2